Karen Herlyn

2.4k total citations
39 papers, 1.8k citations indexed

About

Karen Herlyn is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Physiology. According to data from OpenAlex, Karen Herlyn has authored 39 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pulmonary and Respiratory Medicine, 20 papers in Rheumatology and 9 papers in Physiology. Recurrent topics in Karen Herlyn's work include Vasculitis and related conditions (27 papers), Otitis Media and Relapsing Polychondritis (13 papers) and Sarcoidosis and Beryllium Toxicity Research (7 papers). Karen Herlyn is often cited by papers focused on Vasculitis and related conditions (27 papers), Otitis Media and Relapsing Polychondritis (13 papers) and Sarcoidosis and Beryllium Toxicity Research (7 papers). Karen Herlyn collaborates with scholars based in Germany, United States and United Kingdom. Karen Herlyn's co-authors include Wolfgang L. Gross, E. Reinhold‐Keller, Peter A. Merkel, Kirsten de Groot, Philip Seo, Raashid Luqmani, Bernhard Hellmich, Julia U. Holle, Jan Voswinkel and Konstanze Holl‐Ulrich and has published in prestigious journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and Inflammatory Bowel Diseases.

In The Last Decade

Karen Herlyn

38 papers receiving 1.7k citations

Peers

Countries citing papers authored by Karen Herlyn

Since Specialization

Citations

This map shows the geographic impact of Karen Herlyn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Herlyn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Herlyn more than expected).

Fields of papers citing papers by Karen Herlyn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Herlyn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Herlyn. The network helps show where Karen Herlyn may publish in the future.

Co-authorship network of co-authors of Karen Herlyn

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Herlyn. A scholar is included among the top collaborators of Karen Herlyn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Herlyn. Karen Herlyn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Trends in bone mineral density in young adults with cystic fibrosis over a 15 year period 2015 ·Journal of Cystic Fibrosis ·Melissa S. Putman, Joshua F. Baker, Ahmet Uluer, Karen Herlyn, Allen Lapey, Leonard Sicilian, (unknown), Catherine M. Gordon, Peter A. Merkel, Joel S. Finkelstein	33
2	Body composition, lung function, and prevalent and progressive bone deficits among adults with cystic fibrosis 2015 ·Joint Bone Spine ·Joshua F. Baker, Melissa S. Putman, Karen Herlyn, (unknown), Joel S. Finkelstein, Peter A. Merkel	15
3	Doubled prevalence rates of ANCA-associated vasculitides and giant cell arteritis between 1994 and 2006 in northern Germany 2014 ·Lara D. Veeken ·Karen Herlyn, (unknown), (unknown), (unknown)	63
4	Toll-like receptor TLR2 and TLR9 ligation triggers neutrophil activation in granulomatosis with polyangiitis 2013 ·Lara D. Veeken ·Julia U. Holle, (unknown), Christian M. Lange, W. L. Gross, Karen Herlyn, Elena Csernok	28
5	Rituximab for refractory granulomatosis with polyangiitis (Wegener's granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations 2011 ·Annals of the Rheumatic Diseases ·Julia U. Holle, (unknown), Karen Herlyn, Martin Heller, Petra Ambrosch, Bernhard Noelle, E. Reinhold‐Keller, Wolfgang L. Gross	134
6	Health‐related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody–associated vasculitis 2011 ·Arthritis Care & Research ·Michael Walsh, Chetan Mukhtyar, Alfred Mahr, Karen Herlyn, Raashid Luqmani, Peter A. Merkel, David Jayne	52
7	Health-related quality of life in patients with ANCA-associated vasculitis: a pooled analysis of four randomized clinical trials 2009 ·Apmis ·(unknown), (unknown), Alfred Mahr, Karen Herlyn, Raashid Luqmani, David Jayne	1
8	Progress Towards a Core Set of Outcome Measures in Small-vessel Vasculitis. Report from OMERACT 9 2009 ·The Journal of Rheumatology ·Peter A. Merkel, Karen Herlyn, Alfred Mahr, Tuhina Neogi, Philip Seo, Michael Walsh, Maarten Boers, Raashid Luqmani	32
9	Expansion of circulating NKG2D+ effector memory T-cells and expression of NKG2D-ligand MIC in granulomaous lesions in Wegener's granulomatosis 2008 ·Clinical Immunology ·(unknown), Antje Müller, Elena Csernok, Wolfgang L. Gross, Konstanze Holl‐Ulrich, John Northfield, Paul Klenerman, Karen Herlyn, Julia U. Holle, Stefan Gottschlich, Jan Voswinkel, Thomas A. Spies, (unknown), Wolfram J. Jabs, Peter Lamprecht	53
10	Nutrient Status of Adults with Cystic Fibrosis 2007 ·Journal of the American Dietetic Association ·Catherine M. Gordon, Ellen J. Anderson, Karen Herlyn, Jane Hubbard, (unknown), Rondi B. Gelbard, Allen Lapey, (unknown)	35
11	B-Lymphozyten-Differenzierung in granulomatösen Geweben der Lunge und der Nasenschleimhäute beim Morbus Wegener 2007 ·Zeitschrift für Rheumatologie ·Jan Krämer, Andreas Müller, Karen Herlyn, Silke Pitann, Peter Lamprecht, Konstanze Holl‐Ulrich, Alfred C. Feller, W L Gross, Angela Gause, Jan Voswinkel	3
12	Ein neues Schulungsprogramm—ein Statusbericht: Vaskulitis 2005 ·Zeitschrift für Rheumatologie ·Karen Herlyn, (unknown), Wolfgang L. Gross, E. Reinhold‐Keller	4
13	BPI‐ANCA of pediatric cystic fibrosis patients can impair BPI‐mediated killing of E. coli DH5α in vitro 2004 ·Pediatric Pulmonology ·Hendrik Schultz, Susanne Schinke, (unknown), Karen Herlyn, Antje Schuster, Wolfgang L. Gross	22
14	Autoantibodies Against the Bactericidal/Permeability-Increasing Protein from Inflammatory Bowel Disease Patients Can Impair the Antibiotic Activity of Bactericidal/Permeability-Increasing Protein 2004 ·Inflammatory Bowel Diseases ·Susanne Schinke, Klaus Fellermann, Karen Herlyn, (unknown), (unknown), Eduard F. Stange, Wolfgang L. Gross, Hendrik Schultz	29
15	Effect of Wegener's granulomatosis on work disability, need for medical care, and quality of life in patients younger than 40 years at diagnosis 2002 ·Arthritis Care & Research ·E. Reinhold‐Keller, Karen Herlyn, (unknown), (unknown), H. H. Peter, Heiner Raspe, Wolfgang L. Gross	46
16	Wissenschaftlich begründete Patientenschulung am Beispiel der Patienten mit primär systemischen Vaskulitiden Das Vaskulitis-Schulungsprogramm – Entwicklung, Inhalte und erste Ergebnisse der Evaluation 2002 ·Zeitschrift für Rheumatologie ·Karen Herlyn, (unknown), Wolfgang L. Gross, E. Reinhold‐Keller	4
17	Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon 2002 ·Arthritis & Rheumatism ·Peter A. Merkel, Karen Herlyn, Richard W. Martin, Jennifer J. Anderson, Maureen D. Mayes, (unknown), Joseph H. Korn, Robert W. Simms, Mary Ellen Csuka, Thomas A. Medsger, Naomi F. Rothfield, Michael H. Ellman, David H. Collier, Arthur Weinstein, Daniel E. Furst, Sergio A. Jiménez, Barbara White, James R. Seibold, Fredrick M. Wigley	246
18	High rate of renal relapse in 71 patients with Wegener's granulomatosis under maintenance of remission with low‐dose methotrexate 2002 ·Arthritis Care & Research ·E. Reinhold‐Keller, (unknown), Karen Herlyn, Wolfgang L. Gross, Kirsten de Groot	99
19	Interdisziplinäre Betreuung von Vaskulitis-Patienten: Der Internist/Rheumatologe 2001 ·Zeitschrift für Rheumatologie ·E. Reinhold‐Keller, Karen Herlyn	1
20	Long-term tolerability of methotrexate at doses exceeding 15 mg per week in rheumatoid arthritis 1996 ·Rheumatology International ·A. Schnabel, Karen Herlyn, (unknown), E. Reinhold‐Keller, Wolfgang L. Gross	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact